Sergei Kusmartsev

Publications

PD-L1⁺ and Hyal2⁺ myeloid cells in renal cell carcinoma: a case report

Identification of Hyal2-expressing tumor-associated myeloid cells in cancer: implications for cancer-related inflammation through enhanced hyaluronan degradation

High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma.
Journal of kidney cancer and VHL
2022

Detection of PD-L1–Expressing Myeloid Cell Clusters in the Hyaluronan-Enriched Stroma in Tumor Tissue and Tumor-Draining Lymph Nodes
The Journal of Immunology
2022

Hyal2 Expression in Tumor-Associated Myeloid Cells Mediates Cancer-Related Inflammation in Bladder Cancer
Cancer Research
2021

Editorial: Roles of Tumor-Recruited Myeloid Cells in Immune Evasion in Cancer.
Frontiers in immunology
2021

Acute Kidney Injury–Induced Systemic Inflammation and Risk of Kidney Cancer Formation
Cancer Research
2021

Mechanisms of immune evasion in bladder cancer
Cancer Immunology, Immunotherapy
2020

Calcium Oxalate Differentiates Human Monocytes Into Inflammatory M1 Macrophages.
Frontiers in immunology
2018

COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells.
Proceedings of the National Academy of Sciences of the United States of America
2017

Calcium Oxalate Stone Fragment and Crystal Phagocytosis by Human Macrophages.
The Journal of urology
2016

Expansion of CCR8(+) inflammatory myeloid cells in cancer patients with urothelial and renal carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research
2013

Enhanced 15-lipoxygenase activity and elevated eicosanoid production in kidney tumor microenvironment contribute to the inflammation and immune suppression.
Oncoimmunology
2012

Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer.
International journal of cancer
2012

Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway.
Cancer research
2011

Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells.
International immunopharmacology
2011

Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells.
Journal of leukocyte biology
2010

Identification of ROS using oxidized DCFDA and flow-cytometry.
Methods in molecular biology (Clifton, N.J.)
2010

Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine.
Cancer immunology, immunotherapy : CII
2010

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.
Journal of immunology (Baltimore, Md. : 1950)
2009

Generation of Antigen-Presenting Cells From Tumor-Infiltrated Cd11B Myeloid Cells With Dna Demethylating Agent 5-Aza-2 `-Deoxycytidine
Journal of Immunotherapy
2009

Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
Molecular cancer therapeutics
2009

Enhancing the efficacy of cancer vaccines in urologic oncology: new directions.
Nature reviews. Urology
2009

Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth.
The Prostate
2009

Bcl-2 mediated modulation of vascularization in prostate cancer xenografts.
The Prostate
2009

Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer.
Journal of immunology (Baltimore, Md. : 1950)
2009

Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research
2008

Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.
Journal of immunology (Baltimore, Md. : 1950)
2008

Reversal of tumor-mediated immunosuppression.
Clinical cancer research : an official journal of the American Association for Cancer Research
2007

Role of immature myeloid cells in mechanisms of immune evasion in cancer.
Cancer immunology, immunotherapy : CII
2006

Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer.
Cancer metastasis reviews
2006

Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells.
Journal of immunology (Baltimore, Md. : 1950)
2005

STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion.
Journal of immunology (Baltimore, Md. : 1950)
2005

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.
Journal of immunology (Baltimore, Md. : 1950)
2004

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.
Journal of immunology (Baltimore, Md. : 1950)
2004

Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species.
Journal of leukocyte biology
2003

Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
2003

Effect of individual and combination treatment with cytokines on expression of sialoadhesin by bone marrow macrophages.
Bulletin of experimental biology and medicine
2003

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.
Cancer research
2003

Immature myeloid cells and cancer-associated immune suppression.
Cancer immunology, immunotherapy : CII
2002

Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.
Journal of immunology (Baltimore, Md. : 1950)
2000

[The role of interferon-gamma in the regulation of antiproliferative activity of nonadherent bone marrow cells].
Biulleten' eksperimental'noi biologii i meditsiny
1999

[Suppressor and antineoplastic activity of the bone marrow and spleen cells in aging AKR mice].
Biulleten' eksperimental'noi biologii i meditsiny
1999

[Mechanisms of preleukemic hypoplasia of bone marrow erythroid stem cells in mice AKR/JY].
Biulleten' eksperimental'noi biologii i meditsiny
1999

[Functional reserves of the pool of committed bone marrow hematopoietic precursors in AKR/JY mice during preleukemic period].
Biulleten' eksperimental'noi biologii i meditsiny
1999

[Adaptive potential of granulocytic stem cells in the bone marrow from preleukemic AKR mice].
Biulleten' eksperimental'noi biologii i meditsiny
1999

Sialoadhesin expression by bone marrow macrophages derived from Ehrlich-tumor-bearing mice.
Cancer immunology, immunotherapy : CII
1999

[Suppressor activity of bone marrow cells in patients with stomach neoplasms. Effect of prostaglandins, growth transforming factor-beta, and nitric oxide].
Biulleten' eksperimental'noi biologii i meditsiny
1998

[Structure-functional organization of the bone marrow in dynamics of aging of AKR/J mice].
Biulleten' eksperimental'noi biologii i meditsiny
1998

[Expression of the bone marrow macrophage receptors during cytostatic myelosuppression].
Biulleten' eksperimental'noi biologii i meditsiny
1998

Immunosuppressive cells in bone marrow of patients with stomach cancer.
Advances in experimental medicine and biology
1998

[The possible glyciram stimulation of bone marrow hematopoiesis under cytostatic blood depression].
Eksperimental'naia i klinicheskaia farmakologiia
1995

[Differential induction of natural suppressor activity of bone marrow cells in vitro by various types of tumors].
Biulleten' eksperimental'noi biologii i meditsiny
1995

[Reduced antitumoral and suppressor activity of nonadherent bone marrow cells during culturing in a mixture with supernatant of Ehrlich tumor].
Biulleten' eksperimental'noi biologii i meditsiny
1994

[The effect of cells presenting the erythroblast antigen on the natural suppressor activity of nonadhesive bone marrow cells].
Biulleten' eksperimental'noi biologii i meditsiny
1993

[Suppressor activity of bone marrow and spleen cells in C57Bl/6 mice during carcinogenesis induced by 7,12-dimethylbenz(a)anthracene].
Eksperimental'naia onkologiia
1989

[The activity of nonspecific bone marrow and spleen suppressors in the latent period of tumor growth].
Voprosy onkologii
1988